Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 88427A107 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Nantahala Capital Management, LLC
13G/A
Amendment 1
|
0% |
11/14/2025
Event 9/30/2025
|
|
| Nantahala Capital Management, LLC | 0% | ||
| Wilmot B. Harkey | 0% | ||
| Daniel Mack | 0% | ||
|
Nantahala Capital Management, LLC
13G
|
6.5% |
5/15/2025
Event 3/31/2025
|
|
| Nantahala Capital Management, LLC | 6.5% | ||
| Wilmot B. Harkey | 6.5% | ||
| Daniel Mack | 6.5% | ||
|
EcoR1 Capital, LLC
13G/A
Amendment 2
|
0% |
5/15/2025
Event 3/31/2025
|
|
| EcoR1 Capital, LLC | 0% | ||
| Oleg Nodelman | 0% | ||
| EcoR1 Capital Fund Qualified, L.P. | 0% | ||
|
FMR LLC
13G/A
Amendment 1
|
0% |
5/12/2025
Event 3/31/2025
|
|
| FMR LLC | 0% | ||
| Abigail P. Johnson | 0% | ||
|
Biotechnology Value Fund L P
13G/A
Amendment 3
|
0% |
4/16/2025
Event 4/14/2025
|
|
| Biotechnology Value Fund L P | 0% | ||
| BVF I GP LLC | 0% | ||
| Biotechnology Value Fund II LP | 0% | ||
| BVF II GP LLC | 0% | ||
| Biotechnology Value Trading Fund OS LP | 0% | ||
| BVF Partners OS Ltd. | 0% | ||
| BVF GP Holdings LLC | 0% | ||
| BVF Partners L P/IL | 0% | ||
| BVF Inc/IL | 0% | ||
| Lampert Mark N | 0% | ||
| BML Investment Partners, L.P. 13G | 8.2% |
2/14/2025
Event 2/11/2025
|
|
|
General Atlantic, L.P.
13D/A
Amendment 2
|
0% |
2/13/2025
Event 2/11/2025
|
|
| General Atlantic, L.P. | 0% | ||
| GAP (Bermuda) L.P. | 0% | ||
| General Atlantic GenPar (Bermuda), L.P. | 0% | ||
| General Atlantic Partners 100, L.P. | 0% | ||
| General Atlantic Partners (Bermuda) EU, L.P. | 0% | ||
| General Atlantic (SPV) GP, LLC | 0% | ||
| General Atlantic (Lux) S.a r.l. | 0% | ||
| GAP Coinvestments III, LLC | 0% | ||
| GAP Coinvestments IV, LLC | 0% | ||
| GAP Coinvestments V, LLC | 0% | ||
| GAP Coinvestments CDA, L.P. | 0% | ||
| General Atlantic GenPar (Lux) SCSp | 0% | ||
| General Atlantic Partners (Lux) SCSp | 0% | ||
| General Atlantic (TH), L.P. | 0% | ||
| General Atlantic GenPar, L.P. | 0% | ||
|
FMR LLC
13G
|
5.6% |
2/12/2025
Event 12/31/2024
|
|
| FMR LLC | 5.6% | ||
| Abigail P. Johnson | 5.6% | ||
|
General Atlantic, L.P.
13D/A
Amendment 1
|
8.0% |
1/22/2025
Event 1/17/2025
|
|
| General Atlantic, L.P. | 8.0% | ||
| GAP (Bermuda) L.P. | 8.0% | ||
| General Atlantic GenPar (Bermuda), L.P. | 8.0% | ||
| General Atlantic Partners 100, L.P. | 8.0% | ||
| General Atlantic Partners (Bermuda) EU, L.P. | 8.0% | ||
| General Atlantic (SPV) GP, LLC | 8.0% | ||
| General Atlantic (Lux) S.a r.l. | 8.0% | ||
| GAP Coinvestments III, LLC | 8.0% | ||
| GAP Coinvestments IV, LLC | 8.0% | ||
| GAP Coinvestments V, LLC | 8.0% | ||
| GAP Coinvestments CDA, L.P. | 8.0% | ||
| General Atlantic GenPar (Lux) SCSp | 8.0% | ||
| General Atlantic Partners (Lux) SCSp | 8.0% | ||
| General Atlantic (TH), L.P. | 8.0% | ||
| General Atlantic GenPar, L.P. | 8.0% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 1 | 458 | $2.46 k |
| 2026 Q2 | 4 | 21.5 k | $110 k |
| 2026 Q1 | 4 | 21.5 k | $110 k |
| 2025 Q4 | 4 | 21.7 k | $111 k |
| 2025 Q3 | 18 | 4.33 M | $1.19 M |
| 2025 Q2 | 114 | 40.0 M | $217 M |
| 2025 Q1 | 104 | 38.7 M | $134 M |
| 2024 Q4 | 100 | 45.0 M | $463 M |
| 2024 Q3 | 88 | 44.0 M | $597 M |
| 2024 Q2 | 82 | 40.4 M | $525 M |
| 2024 Q1 | 75 | 38.6 M | $364 M |
| 2023 Q4 | 66 | 39.1 M | $429 M |
| 2023 Q3 | 59 | 37.8 M | $242 M |
| 2023 Q2 | 50 | 36.1 M | $173 M |
| 2023 Q1 | 52 | 36.4 M | $150 M |
| 2022 Q4 | 52 | 35.8 M | $154 M |
| 2022 Q3 | 41 | 35.5 M | $673 M |